Nicotinamide mononucleotide inhibits oxidative stress-induced damage in a SIRT1/NQO-1-dependent manner.


Journal

Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 02 05 2023
revised: 23 08 2023
accepted: 25 08 2023
medline: 23 10 2023
pubmed: 29 8 2023
entrez: 28 8 2023
Statut: ppublish

Résumé

Oxidative stress causes endothelial dysfunction, which is associated with vascular cellular aging and is causally related to cardiovascular disease pathogenesis. Preclinical studies indicate that a nicotinamide adenine dinucleotide (NAD

Identifiants

pubmed: 37640247
pii: S0887-2333(23)00132-7
doi: 10.1016/j.tiv.2023.105683
pii:
doi:

Substances chimiques

Actins 0
Hydrogen Peroxide BBX060AN9V
NAD 0U46U6E8UK
Nicotinamide Mononucleotide 1094-61-7
SIRT1 protein, human EC 3.5.1.-
Sirtuin 1 EC 3.5.1.-
NQO1 protein, human EC 1.6.5.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105683

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

T Nakajo (T)

DHC Corporation Laboratories, Division 2, 2-42 Hamada, Mihama-ku, Chiba 261-0025, Japan. Electronic address: tnakajo@dhc.co.jp.

N Kitajima (N)

DHC Corporation Laboratories, Division 2, 2-42 Hamada, Mihama-ku, Chiba 261-0025, Japan. Electronic address: nkitajima@dhc.co.jp.

T Katayoshi (T)

DHC Corporation Laboratories, Division 2, 2-42 Hamada, Mihama-ku, Chiba 261-0025, Japan. Electronic address: t-katayoshi@dhc.co.jp.

K Tsuji-Naito (K)

DHC Corporation Laboratories, Division 2, 2-42 Hamada, Mihama-ku, Chiba 261-0025, Japan. Electronic address: knaito@dhc.co.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH